Search PubMed⌕ Search

Biomedical subjects

Y Fan

Publications and source records attributed to Y Fan.

At least 163 records · Page 9Linked to original sources

Recombinant human granulocyte colony-stimulating factor after allogeneic bone marrow transplantation.

OBJECTIVE: To examine the effect of rhG-CSF on allogeneic bone marrow transplantation. PATIENTS AND METHODS: One hundred and twenty patients with acute or chronic leukemia received HLA-A.B.DR identical and MLC negative sibling donor allo-BMT. Among them, 58 cases of were treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF), while the other 62 cases of the 120 patients were treated as control. RESULTS: Clinical results showed that the time taken to reach an absolute neutrophil count > 0.5 x 10(9)/L was significantly faster in patients who received rhG-CSF compared with control patients (16.24 +/- 0.25 vs 25.20 +/- 0.16 days. P < 0.001), with significantly less early fever days in patients received rhG-CSF (1.17 +/- 1.10 vs 4.01 +/- 0.37 P < 0.001). We did not observe any increase in acute GVHD and relapse in myeloid leukemia patients. But 7 of 16 patients with ALL relapsed after allo-BMT in rhG-CSF group, while only 3 of 11 patients with ALL relapsed after allo-BMT in control grant (P > 0.05). This phenomenon has not been reported up to now. CONCLUSIONS: rhG-CSF can promote engraftment and reduce early fever days after BMT. rhG-CSF has not any effect on a GVHD. The effect of rhG-CSF on leukemia relapse needs to be further studied.

Adolescent↗

[Improvement on bilateral cleft lip repair].

The deformity of the bilateral cleft lip is complicated. The routine procedure often results in secondary deformities, such as over-tight lip, and over-thin vermilion. The paper introduces a modified straight-line procedure that has been used in 16 patients with satisfactory results. This one-stage procedure employed a nasolabial flap and two small triangular flaps to lessen the tension of sutrue and lengthen the anterior lip as well as create a natural feature of the vermillion border. The method overcame imperfection of routine ones and achieved functional repair of the lip that would facilitate the development of the columella and anterior lip.

Child, Preschool↗

Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.

Human HT1080 fibrosarcoma cells, subclone H4, express little or no Egr-1 (Zif/268, Krox 24), an early growth response gene encoding a transcription factor. Phorbol ester (but not serum) treatment only can elicit a small increase in Egr-1 expression in H4, in contrast to the normally rapid, high transient expression of Egr-1 observed after the addition of a wide range of stimulating agents to normal or immortalized cell lines. Because several human tumor cell lines express little Egr-1, we tested the hypothesis that this loss was causal to transformation. We report here that the expression of exogenous mouse Egr-1 in H4 cells inhibits transformed growth in a dose-dependent manner and significantly suppresses tumorigenicity in athymic mice. By overexpression of the fragment in Egr-1 that is responsible for its DNA-binding activity, the zinc-finger domain, we show that this domain has a similar activity. Moreover, the expression of antisense mRNA encoding the DNA-binding domain increases the transformed character of the H4 cells. One possible conclusion is that endogenous Egr-1-like genes perform growth-regulatory functions. Other human tumor lines are also growth suppressed by Egr-1 overexpression including ZR-75-1 breast carcinoma, U251 glioblastoma, and to a lesser extent, SAOS-2 osteosarcoma cells. These results are surprising in light of the "early growth response" character of Egr-1 but extend our earlier report of suppression of growth in v-sis-transformed NIH3T3 cells.

Animals↗

Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.

Although giant cell tumor of bone (GCT) is generally considered to be an uncommon benign neoplasm, it can pursue an aggressive course with local recurrence and metastasis. Attempts to predict the biological behavior of GCT with histopathological parameters, however, have not been successful. The urokinase-type plasminogen activation system has been implicated in tumor invasion and metastasis and abnormalities of the components of this system have been found in several malignancies. In this study we postulated that the urokinase-type plasminogen activation system associated with bone destruction and local invasion is present in GCT. We therefore evaluated the mRNA levels for urokinase-type plasminogen activator (u-PA), urokinase-type plasminogen activator receptor (u-PAR), and plasminogen activator inhibitor type 1 (PAI-1) by using Northern blot analysis and in situ hybridization in four cases of GCT and spindle-shaped mononuclear cells at the 35th passage from a GCT. Our results showed that giant cell tumors of bone contained variable levels of u-PA, u-PAR, and PAI-1 mRNA, respectively, 2.3, 1.4, and 3.2 kb in size. In situ hybridization showed that u-PA, u-PAR, and PAI-1 mRNA were expressed in both the mononuclear cells and the osteoclast-like giant cells; the signal for u-PA mRNA in the spindle-shaped mononuclear cells was more intense than that in the osteoclast-like multinuclear giant cells. Some spherical mononuclear cells (macrophage-like cells) expressed high levels of PAI-1 mRNA in comparison with the spindle-shaped mononuclear cells. In addition, the 35th passaged spindle-shaped mononuclear cells were used to study the gene expression of u-PA during cell proliferation. The results showed that the level of u-PA mRNA increases after adding 10% fetal calf serum to quiescent cells. The induction was maximal at 16 hours and remained high during 48 hours of treatment. In conclusion, even though osteoclast-like cells are ultimately responsible for the bone resorption of GCT, the mononuclear neoplastic cells of GCT may also be involved in degradation of the extracellular matrix during invasive growth by facilitating the urokinase plasminogen activation system. In addition, our observation of upregulation of u-PA mRNA in spindle-shaped mononuclear cells after serum stimulation indicated that u-PA production may be linked to tumor growth.

Adult↗

Highly insect-resistant transgenic tobacco plants containing both B.t. and CpTI genes.

The cowpea trypsin inhibitor (CpTI) gene was synthesized according to its cDNA sequence using DNA synthesizer and confirmed by DNA sequencing. The CpTI gene and modified Bacillus thuringiensis (B.t.) delta-endotoxin gene were cotransformed to tobacco explants mediated by Agrobacterium tumefaciens. The integrations of B.t and CpTI genes were confirmed by PCR and Southern hybridization. Three kinds of transgenic plants were obtained: (1) containing CpTI gene, (2) containing B.t gene, (3) containing both CpTI and B.t genes. Bioassays showed that all these transgenic plants were toxic to the larvae of Heliothis armigera and that the tobacco plants containing both genes had enhanced toxicity to larvae by comparison with plants containing only CpTI or B.t gene.

Agrobacterium tumefaciens↗

A new animal model of coronary thrombosis and effects of antithrombotic agents.

The model was established in male rabbits with experimental atherosclerosis, which was induced by diet cholesterol (0.5 g per day for 8 weeks), by means of intravenous injection of one unit of pituitrin (P.P.). To evaluate the effects of aspirin, heparin and viper venom (VV) on this model, 26 male rabbits were divided randomly into four groups: group A (GA) as control, group B (GB) treated with heparin (10mg, i.v.), group C (GC) with VV (0.08 arginine esterase activity units), group D (GD) with both heparin and VV. Aspirin (30 mg) was given orally before experiment. The results showed that the rate of coronary thrombosis was 11.26% in GA, 8.10% in GB, 9.17% in GC, and 7.56% in GD respectively. The difference between each of three treated groups and the control one was significant (P < 0.005, 0.05, 0.001, respectively). Such a difference can also be found between GA and that without oral aspirin (11.26% vs 16.39%, P < 0.001). The beneficial effects of heparin and VV may be due to their inhibitory effects on different steps of thrombosis, i.e., heparin can prolong the coagulation time, and VV can inhibit platelet aggregation and decrease the concentration of plasma fibrinogen. It is concluded that heparin, viper venom, and especially their combination would be useful in the treatment of human acute coronary syndromes.

Animals↗

[A preliminary study on bioactivity of orange and tangerine peel extracts against aphis and mites].

An assay was made on the bioactivity of the extracts of tangerine peel from Cinocitrus tangerina, orange peel from Citrus sinensis and mixed tangerine peel from Cinocitrus sp. against aphis Semia phis heraclei, Aphis craccivora, Uroleucon gobonis and Myzus persicae using residual film or topical method, and against mites Tetranychus viennensis and T. trancatus using slide-dip or immersion method. Test results show that these extracts have strong bioactivity against aphids and mites. The corrected mortality regression equations and LC50 (or LD50) of these extracts to pests are presented.

Animals↗

[Whole organ subserial section examination of occult breast carcinoma].

In mastectomy specimens, the primary foci of occult breast carcinoma were examinated usually by routine histopathological method, but the result was not satisfactory. The detecting rates of primary foci were 50%-56% in China and 45%-75% in some other countries. In this study, whole organ subserial section was performed in 20 cases of occult breast cancer from April, 1988 to February, 1994. Primary foci were found in 16 cases (80%) by microscopic examination. Diameters of 10 foci were less than 1.0cm and the smallest one was 0.3 x 0.1 x 0.1cm. In addition, occult breast cancer with multiple foci was detected in 5 cases (31.25%), which would be very difficult to be found by routine histopathological examination. The possible causes for the failure of detection of the primary foci on whole organ section are discussed.

Adenocarcinoma↗

Interaction between intercalation type anticancer drugs and DNA studied by ultraviolet resonance Raman spectroscopy.

The interaction of typical intercalation type anticancer drugs, adriamycin (ADM) and aclacinomycin (ACM), with calf thymus DNA was studied first with ultraviolet resonance Raman spectroscopy (UVRRS). The results demonstrate that the important information such as intercalation sites of drugs, the electronic interaction and the hydrogen bonds between drugs and DNA can be obtained by UVRRS. The method can also show the influence of drugs on DNA conformation and hydrogen bonds between bases of DNA.

Aclarubicin↗

[Ondansetron in the prophylaxis of acute emesis induced by supra-high single dose total body irradiation (TBI)].

One hundred sixteen cases of leukemia patients received supra-high single dose TBI for bone marrow transplantation (BMT) with total a radiation dosage of 700-770 Gy at about 5cGy/min. Seventy patients were given ondanstron (8mg) plus dexamethasone (DXM, 10mg) for prophylaxis of TBI-induced acute nausea and vomiting, 46 patients were given paspertin (10mg) plus dexamethasone (10mg) as controls. The clinical results showed that ondansetron plus DXM achieved complete or major control of vomiting in 59/70 (84%) of cases and there was little or no nausea in 61/70 (87%), while paspertin plus DXM achieved complete or major control of vomiting only in 9/46 (20%) of cases and little or no nausea in 5/46 (11%). It is concluded that ondansetron has significantly greater advantage over paspertin in the control of acute emesis induced by TBI.

Adult↗

Experimental study on antiatherosclerotic treatment by PGE2 combined with vitamin E and estradiol.

The effects of single dose of PGE2 combined with vitamin E and with estradiol on experimental atherosclerosis were studied by means of morphological, ultrastructural, autoradiographic and several functional techniques. The results showed that two combined treatment groups had more coordinative inhibition on aortic and coronary atherosclerotic lesions, as well as on platelet aggregation, smooth muscle cell proliferation and lipid peroxidation than that of single dose of PGE2. It was revealed that the coordinative mechanism might be closely related to the synergistic inhibitory function of above-mentioned drugs on endothelial permeability, platelet aggregation, smooth muscle cell proliferation and lipid peroxidation.

Animals↗

[Detection of hypermethylation in affected males with fragile X syndrome by PCR assay].

PCR technique was applied to detect hypermethylation at BssH II recognition sites within CpG island of FMR-1 gene in normal, affected, and clinically suspected males with fragile X syndrome. Hypermethylation was found to occur in all 7 affected and 5 of 26 suspected, but none of 15 normal males. The results of PCR assay are in good coincidence with those of Southern blot and cytogenetic assays. This PCR assay will be a promising method in the diagnosis of fragile X syndrome in males with mental retardation.

Base Sequence↗

[Detection of FMR-1 gene expression by RT-PCR].

Fragile X syndrome [FRA(X)] as the most common form of inherited mental retardation in man has an incidence of one per 1250 and is associated with a fragile site at Xq27.3. A gene was identified at the fragile X locus and was designated Fragile X Mental Retardation-1 (FMR-1). FRA(X) resulted from expansion of (CGG)n trinucleotide repeat in 5' untranslated region of the human FMR-1 gene, and was associated with abnormal methylation of a CpG island 250 bp proximal to this (CGG)n repeat. Males with typical FRA(X) showed repression of FMR-1 transcription and absence of FMR-1 protein, which was believed to contribute to the fragile X phenotype. FMR-1 mRNA extracted from leukocytes in normal and clinically suspected males were detected by RT-PCR. The methylation status and CGG expansion were also studied by PCR and Southern blot. Two of 10 clinically suspected males were found devoid of FMR-1 expression and accompanied with hypermethylation of the CpG island and CGG trinucleotide repeat expansion.

CpG Islands↗

Dual pathways for GTP-dependent regulation of chemoattractant-activated K+ conductance in murine J774 monocytes.

Whole-cell patch clamp recording and digital imaging microscopy were used to investigate the electrical and calcium signaling responses of murine J774 monocytes to chemoattractants and other calcium-mobilizing agonists. A latent outwardly rectifying K+ conductance, GkOR, was elicited within seconds by each of the following agonists: C5a, ATP, ADP, interleukin-8, and the adenosine analog 5'-(N-ethylcarboxamido)-adenosine. In terms of its pharmacologic profile and current-voltage (I-V) relation, GkOR was very similar to a P2 purinoceptor-activated K+ conductance previously described in rat mast cells and to a K+ conductance elicited in J774 cells by the GTP analog guanosine 5'-O-(3-thiotriphosphate). Agonist-induced elevation of calcium, primarily due to intracellular release, and the induction of GkOR both required a GTP-binding protein of the Gi family, as both events were blocked by pertussis toxin; intracellular dialysis with guanosine 5'-O-(2-thiodiphosphate) also prevented the induction of GkOR, further implicating mediation by a G protein. Induction of GkOR did not depend upon influx of Ca2+, as it occurred equally well when the concentration of external Ca2+ was 100 nM or 2 mM. We attempted to uncouple agonist-induced calcium release from induction of GkOR by dialyzing the cell cytoplasm with Ca(2+)-EGTA or Ca(2+)-1,2-bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) buffers before agonist application. When the concentration of free Ca2+ ([Ca2+]i) was set to approximately 15 nM with 1.1 or 11 mM EGTA, a "slow"Ca2+ buffer, 10 nM C5a induced a large GkOR (11 nS at 1.1 mM EGTA versus 13.4 nS at 11 mM EGTA). Surprisingly, when [Ca2+]i was buffered at 15 nM with 10 mM BAPTA, a "rapid" Ca2+ buffer, C5a elicited a much smaller although significant K+ conductance (approximately 3 nS). Systematic increase in cytosolic [Ca2+]i upon dialysis with a series of 10 mM BAPTA-Ca2+ buffers (15-2400 nM [Ca2+]i) revealed activation of a very large K+ conductance (maximum 17.4 nS), even in the presumed absence of receptor stimulation. This conductance had a similar I-V relationship to GkOR, and activation occurred within the range of [Ca2+]i observed in intact cells following stimulation with C5a or ADP (EC50 approximately 475 nM [Ca2+]i). Activation of Gk thus may proceed in part via the release of intracellular calcium from a source in close proximity to the channel or other calcium-binding regulatory protein.(ABSTRACT TRUNCATED AT 400 WORDS)

Adenine Nucleotides↗

Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.

Endothelial-monocyte activating polypeptide II (EMAP II) was initially identified in the supernatant of murine methylcholanthrene A-induced fibrosarcomas (Meth A) by its capacity to activate host effector cells (Kao, J., Ryan, J., Brett, J., Chen, J., Shen, H., Fan, Y-G., Godman, G., Familletti, P., Wang, F., Pan, Y-C., Stern, D., and Clauss, M. (1992) J. Biol. Chem. 267, 20239-20247). Based on the NH2-terminal protein sequence, a full-length cDNA has been cloned which indicates that the precursor of EMAP II is a unique, leaderless, single polypeptide chain with predicted molecular mass approximately 34 kDa and that the mature form released by Meth A cells corresponds to approximately 20 kDa. Purified recombinant mature EMAP II (EMAP II, approximately 20 kDa form) activated endothelial cells with resulting elevation of cytosolic free calcium concentration, release of von Willebrand factor, induction of tissue factor, and expression of the adhesion molecules E-selectin and P-selectin. Neutrophils exposed to EMAP II demonstrated elevated cytosolic free calcium concentration, peroxidase generation, and chemotaxis. EMAP II also activated mononuclear phagocytes elevating cytosolic free calcium concentration, inducing tumor necrosis factor-alpha (TNF) and tissue factor, and stimulating chemotaxis. Systemic infusion of EMAP II into C3H/HeJ or Balb/c mice was associated with systemic toxicity, pulmonary congestion, and the appearance of TNF, interleukin-1 and -6 in the plasma. A single intra-tumor injection of EMAP II into Meth A sarcomas induced acute thrombohemorrhage and partial tumor regression. Local injection of EMAP II into a tumor resistant to the effects of TNF, murine mammary carcinoma, rendered it sensitive to subsequently administered TNF, which resulted in acute thrombohemorrhage and partial regression. These data suggest that recombinant EMAP II, a tumor-derived cytokine, has properties of a proinflammatory mediator with the capacity to prime the tumor vasculature for a locally destructive process.

Amino Acid Sequence↗

Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family.

A cDNA was isolated from rat brain by low stringency hybridization with the rat mu opioid receptor cDNA. Sequence analysis of this clone indicated that it contains an open reading frame capable of encoding a 367 amino acid protein. The deduced amino acid sequence of this protein shows high degrees of homology to all three opioid receptors, mu, kappa, and delta, suggesting that it is a member of the opioid receptor gene family. RNA blot analysis detected high level expression of the receptor mRNA in the brain. Southern blot analysis suggests that it is a single-copy gene, and mapping studies localized the gene on mouse chromosome 2. Despite the high sequence homologies between this protein and the other opioid receptors, expression studies of this clone in COS-7 cells did not show binding to [3H]diprenorphine, a ligand that binds to the other three opioid receptors. Furthermore, co-expression of this receptor with a G protein-activated potassium channel in Xenopus oocytes did not show functional coupling upon stimulation with mu, kappa and delta agonists. Given the similar degrees of high homology to the mu, kappa and delta opioid receptors and the lack of apparent affinity for their ligands, this receptor does not appear to belong to any of the three known classes of opioid receptors. Rather, it represents a novel member of the opioid receptor gene family, not identified from previous pharmacological studies.

Amino Acid Sequence↗

Intrinsic differences in MyoD and myogenin expression between primary cultures of SJL/J and BALB/C skeletal muscle.

The time course of expression of the skeletal muscle-specific regulatory genes MyoD and myogenin was studied in primary cultures of skeletal muscle from adult SJL/J and BALB/c mice. In situ detection of expression with MyoD and myogenin riboprobes and myogenin antibody showed that the onset of expression of these genes occurred earlier in cells from SJL/J mice. Probe-positive cells and myotubes were also more frequent in cultures from SJL/J mice than in BALB/c. The onset of expression of MyoD and myogenin was delayed in cultured cells relative to the time course seen following injury in vivo. Myogenin protein was demonstrated in replicating cells and all myogenin-positive cells expressed desmin. The observed strain-specific difference infers a greater intrinsic myogenicity of cells in SJL/J muscle in vitro and reflects the superior capacity for new muscle formation previously reported in SJL/J mice in vivo.

Animals↗